141 results
Page 6 of 8
8-K
EX-99
8y6cw
10 Oct 06
Theravance Announces Additional Results From Successful Phase 3 Telavancin Complicated Skin and Skin Structure Program
12:00am
8-K
EX-99
guhza12pv
22 Aug 06
Theravance Announces Positive Results In Phase 3 Telavancin Complicated Skin and Skin Structure Infection Program
12:00am
8-K
EX-99
flbo5x72g0x7g4
27 Jul 06
Results of Operations and Financial Condition
12:00am
8-K
EX-99
3dhhjxaj
18 Jul 06
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99
84zq8i 0q8f8fa0l477
27 Apr 06
Results of Operations and Financial Condition
12:00am
8-K
EX-99
p0i8 ejx7ao2ebh
9 Feb 06
Results of Operations and Financial Condition
12:00am
424B5
u3dge643e718l
2 Feb 06
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
l8222c
30 Jan 06
Regulation FD Disclosure
12:00am
S-3ASR
nw830i2 8o3xhkdudzl
30 Jan 06
Automatic shelf registration
12:00am
8-K
EX-99.1
mnvjboy
11 Jan 06
Theravance Updates Guidance for Initiation of Phase 2b in the LABA Collaboration
12:00am
8-K
EX-99
f9fkmo4 m4u5u968
12 Dec 05
Departure of Directors or Principal Officers
12:00am
8-K
EX-99
4v9fy6xtmpd0j
8 Nov 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99
s1d0wj5qj7dfb
27 Oct 05
Results of Operations and Financial Condition
12:00am